Product Information
BIKTARVY 50-200-25 MG TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $136.7401 per EA under NDC 61958250103. Its NADAC has been published 259 times since Jul 14, 2021.
BIKTARVY 50-200-25 MG TABLET
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarateStrength
50; 200; 25 mg/1; mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958250103
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA210251On Market Since
2/7/2018
Pharmacological Classes
Price Statistics
The NADAC for BIKTARVY 50-200-25 MG TABLET has been published 259 times since Jul 14, 2021, and over the history we have for it it has risen 24.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $136.7401 per EA |
|---|---|
| All-time high | $136.7403 (Apr 15, 2026) |
| All-time low | $109.4936 (Aug 18, 2021) |
| 52-week high | $136.7403 |
| 52-week low | $136.6967 |
| Median price | $123.0856 |
| Average price | $125.3241 |
| Largest weekly change | +5.9% (Jan 15, 2025) |
| Weeks tracked | 259 |
| Tracking since | Jul 14, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BIKTARVY 50-200-25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BIKTARVY 50-200-25 MG TABLET, manufactured by Gilead Sciences, Inc., is $136.7401 per EA (NDC 61958250103), effective Jun 24, 2026.
How has the price of BIKTARVY 50-200-25 MG TABLET changed over time?
Over the history we have for it, the NADAC for BIKTARVY 50-200-25 MG TABLET has risen 24.8%. It has been tracked across 259 weekly CMS publications since Jul 14, 2021.
What are the highest and lowest recorded NADAC prices for BIKTARVY 50-200-25 MG TABLET?
Since Jul 14, 2021, the NADAC for BIKTARVY 50-200-25 MG TABLET has ranged from a low of $109.4936 (Aug 18, 2021) to a high of $136.7403 (Apr 15, 2026), with a median of $123.0856 per EA.
Are there cheaper alternatives to BIKTARVY 50-200-25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BIKTARVY 50-200-25 MG TABLET, but none are currently priced below it.
Who manufactures BIKTARVY 50-200-25 MG TABLET?
BIKTARVY 50-200-25 MG TABLET (NDC 61958250103) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification